Vitner Dana, Harris Kristin, Maxwell Cynthia, Farine Dan
a Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine , University of Toronto , Toronto , Canada.
b Ruth and Bruce Rappaport Faculty of Medicine , Technion - Israel Institute of Technology , Haifa , Israel.
J Matern Fetal Neonatal Med. 2019 Aug;32(15):2580-2590. doi: 10.1080/14767058.2018.1440546. Epub 2018 Feb 26.
Obesity in pregnancy has become one of the most important challenges in obstetrical care given its prevalence and potential adverse impact on both mother and fetus. The primary objective of this descriptive review is to identify common themes and distinctions within the current recommendations for maternal obesity in the most updated version of four published national guidelines.
We reviewed the following guidelines for obesity in pregnancy: American College of Obstetricians and Gynecologists (ACOG) 2015, Royal Australian and New Zealand College of Obstetricians and Gynecologists (RANZCOG) 2013, Royal College of Obstetrics and Gynecology (RCOG) 2010, and Society of Obstetrics and Gynecologists of Canada (SOGC) 2010.
There were no major contradictions between the guidelines, however, variations did exist. Recognition of overweight and obese populations prenatally was uniformly emphasized, so that appropriate nutrition and exercise counseling could be provided prior to pregnancy. Obesity in pregnancy was consistently defined as a body mass index of 30 kg/m or more, and weight gain recommendations were in line with the Institute of Medicine guidelines. Counseling patients regarding the specific maternal and fetal complications in pregnancy, delivery, and postpartum which are associated with obesity was consistently emphasized. Most guidelines recommended early screening for gestational diabetes, however, specific details were not provided. All guidelines stressed the importance of available resources in clinics and the operating room specific to the obese population. Disparities were found regarding recommendations for high-dose folic acid, vitamin D supplementation, and low-dose aspirin. Thromboprophylaxis is a matter of debate, with most guidelines recommending use on an individual patient basis.
In general, the guidelines emphasized the importance of counseling women regarding the risks associated with obesity in pregnancy, and stressed the necessity of screening for these adverse outcomes. Initiatives to develop common terminology and reporting of outcomes in women's health are important for the development of cohesive and uniform recommendations for patient care. Disparities existed with respect to management strategies and where the further research and systematic reviews should be targeted, to allow clinicians to provide an appropriate obstetrical care pathway for obese women.
鉴于孕期肥胖的普遍性及其对母亲和胎儿的潜在不利影响,孕期肥胖已成为产科护理中最重要的挑战之一。本描述性综述的主要目的是在四份已发表的国家指南的最新版本中,确定当前关于孕产妇肥胖的建议中的共同主题和差异。
我们回顾了以下孕期肥胖指南:美国妇产科医师学会(ACOG)2015年版、澳大利亚和新西兰皇家妇产科医师学院(RANZCOG)2013年版、皇家妇产科医学院(RCOG)2010年版以及加拿大妇产科医师协会(SOGC)2010年版。
这些指南之间没有重大矛盾,但存在差异。均一致强调在产前识别超重和肥胖人群,以便在怀孕前提供适当的营养和运动咨询。孕期肥胖一直被定义为体重指数达到30kg/m²或更高,体重增加建议与医学研究所的指南一致。一直强调向患者咨询与肥胖相关的孕期、分娩期和产后的具体母婴并发症。大多数指南建议早期筛查妊娠期糖尿病,但未提供具体细节。所有指南都强调了诊所和手术室针对肥胖人群的可用资源的重要性。在高剂量叶酸、维生素D补充剂和低剂量阿司匹林的建议方面存在差异。血栓预防存在争议,大多数指南建议根据个体患者情况使用。
总体而言,这些指南强调了向女性咨询孕期肥胖相关风险的重要性,并强调了筛查这些不良结局的必要性。制定女性健康领域通用术语和结局报告的举措对于制定连贯统一的患者护理建议非常重要。在管理策略以及进一步研究和系统评价应针对的方向上存在差异,以便临床医生为肥胖女性提供适当的产科护理路径。